J Gen Virol Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

J Gen Virol 86 (2005), 1753-1757; DOI 10.1099/vir.0.80836-0

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baron, M. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baron, M. D.
Agricola
Right arrow Articles by Baron, M. D.
© 2005 Society for General Microbiology

Short Communication

Wild-type Rinderpest virus uses SLAM (CD150) as its receptor

Michael D. Baron

Institute for Animal Health, Ash Road, Pirbright, Surrey GU24 0NF, UK

Correspondence
Michael D. Baron
michael.baron{at}bbsrc.ac.uk

Rinderpest virus (RPV) is a morbillivirus, related closely to the human pathogen Measles virus (MV). Although cell culture-adapted strains of RPV can infect many kinds of cell from different hosts, one such strain has previously been shown to have a detectable preference for cells expressing the MV receptor CD150 (SLAM), a protein found only on certain types of activated T cells, B cells and dendritic cells. Here, it is shown that the wild-type, virulent parent of the most common vaccine strain of RPV requires CD150 as a receptor, whilst the cell culture-adapted vaccine strain has acquired the ability to use heparan sulphate as an alternative receptor.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
R. W. H. Ruigrok and D. Gerlier
Structure of the measles virus H glycoprotein sheds light on an efficient vaccine
PNAS, December 26, 2007; 104(52): 20639 - 20640.
[Full Text] [PDF]

Home page
 J. Gen. Virol.Home page
Y. Yanagi, M. Takeda, and S. Ohno
Measles virus: cellular receptors, tropism and pathogenesis.
J. Gen. Virol., October 1, 2006; 87(Pt 10): 2767 - 2779.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
S. K. Nanda and M. D. Baron
Rinderpest Virus Blocks Type I and Type II Interferon Action: Role of Structural and Nonstructural Proteins.
J. Virol., August 1, 2006; 80(15): 7555 - 7568.
[Abstract] [Full Text] [PDF]

Home page
 J. Virol.Home page
V. von Messling, N. Svitek, and R. Cattaneo
Receptor (SLAM [CD150]) Recognition and the V Protein Sustain Swift Lymphocyte-Based Invasion of Mucosal Tissue and Lymphatic Organs by a Morbillivirus.
J. Virol., June 1, 2006; 80(12): 6084 - 6092.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 2005 by the Society for General Microbiology.